{'fraction_non_alphanumeric': 0.01362088535754824, 'fraction_numerical': 0.009080590238365494, 'mean_word_length': 5.391304347826087, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Association Study of Apolipoprotein Eε4with Clinical Phenotype and Clozapine Response in Schizophrenia

Schizophrenic patients with the apolipoprotein E (APOE = gene; apoE = protein) ε4 allele exhibited lower psychosis scores than patients without the ε4 allele in previous reports. The present study tested the hypothesis that the APOE ε4 allele confers association with the clinical manifestations of schizophrenia or clozapine response. A total of 95 schizophrenic patients who were treatment resistant were included in the study. The results demonstrated that the presence of the APOE ε4 allele did not influence the response to clozapine in schizophrenic patients, neither was the baseline psychopathology related to the APOE ε4 allele. Given the multiple functions of the apoE protein in the brain, further study of the influence of APOE on CNS medication response is needed.